Mirum Pharmaceuticals Inc (MIRM)
Cost of Revenue
$30.35M
Quarterly · Period ending: · USD
MIRM Cost of Revenue
Latest reported$30.35Mperiod ending
Latest reported$30.35Mperiod ending
MIRM Quarterly Cost of Revenue ($0.00 → $30.35M)
Quarterly cost of revenue
High-resolution chart · PNG
MIRM cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 30,348,000 | |
| 28,879,000 | |
| 28,338,000 | |
| 25,537,000 | |
| 23,421,000 | |
| 23,018,000 | |
| 22,780,000 | |
| 20,806,000 | |
| 20,227,000 | |
| 17,830,000 | |
| 25,020,000 | |
| 10,228,000 | |
| 6,812,000 | |
| 4,979,000 | |
| 4,494,000 | |
| 2,932,000 | |
| 2,524,000 | |
| 2,424,000 | |
| 1,903,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |